AIC
SPRO icon

AWM Investment Company’s Spero Therapeutics SPRO Stock Holding History

AWM Investment Company’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-333,400
Closed -$447K – 98
2024
Q3 		$447K Hold
333,400
– – 0.05% 93
2024
Q2 		$433K Hold
333,400
– – 0.06% 91
2024
Q1 		$573K Hold
333,400
– – 0.08% 103
2023
Q4 		$490K Hold
333,400
– – 0.06% 106
2023
Q3 		$403K Sell
333,400
-50,000
-13% -$69.3K 0.06% 98
2023
Q2 		$556K Sell
383,400
-917,000
-71% -$1.57M 0.08% 99
2023
Q1 		$1.89M Hold
1,300,400
– – 0.26% 77
2022
Q4 		$2.25M Sell
1,300,400
-1,000,000
-43% -$1.87M 0.32% 59
2022
Q3 		$4.6M Buy
+2,300,400
New +$2.29M 0.7% 41
2022
Q2 		– Sell
-372,755
Closed -$3.24M – 123
2022
Q1 		$3.24M Hold
372,755
– – 0.42% 63
2021
Q4 		$5.97M Hold
372,755
– – 0.6% 54
2021
Q3 		$6.86M Hold
372,755
– – 0.67% 50
2021
Q2 		$5.2M Hold
372,755
– – 0.51% 66
2021
Q1 		$5.49M Hold
372,755
– – 0.61% 50
2020
Q4 		$7.23M Sell
372,755
-126,000
-25% -$1.96M 0.92% 41
2020
Q3 		$5.57M Buy
498,755
+255,000
+105% +$3.02M 0.91% 43
2020
Q2 		$3.3M Sell
243,755
-152,194
-38% -$1.71M 0.58% 51
2020
Q1 		$3.2M Sell
395,949
-78,395
-17% -$691K 0.85% 40
2019
Q4 		$4.56M Sell
474,344
-123,971
-21% -$1.34M 0.89% 42
2019
Q3 		$6.34M Hold
598,315
– – 1.35% 28
2019
Q2 		$6.89M Buy
598,315
+36,019
+6% +$434K 1.32% 31
2019
Q1 		$7.2M Buy
562,296
+38,271
+7% +$406K 1.42% 26
2018
Q4 		$3.22M Sell
524,025
-16,449
-3% -$133K 0.7% 51
2018
Q3 		$5.68M Buy
540,474
+400,000
+285% +$4.64M 0.94% 39
2018
Q2 		$2.06M Sell
140,474
-209,526
-60% -$2.68M 0.34% 66
2018
Q1 		$4.99M Hold
350,000
– – 0.96% 36
2017
Q4 		$4.11M Buy
+350,000
New +$4.3M 0.8% 41

Other funds holding SPRO

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWM Investment Company's SPRO Position: Q4 2024 in Review

AWM Investment Company sold out of Spero Therapeutics (SPRO) in Q4 2024, closing a stake of 333,400 shares — an estimated $447K sold.

AWM Investment Company first reported a position in SPRO in Q4 2017 and held it in 27 quarters. The position peaked at $7.23M in Q4 2020. 50 funds tracked by Wall St. Rank hold SPRO as of Q4 2024.

  • AWM Investment Company reported no remaining Spero Therapeutics position as of Q4 2024 after selling out during the quarter.
  • AWM Investment Company sold 333,400 Spero Therapeutics shares in Q4 2024, an estimated $447K.
  • AWM Investment Company first reported a position in Spero Therapeutics in Q4 2017 and held it in 27 quarters.
  • AWM Investment Company's Spero Therapeutics position peaked at $7.23M in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Spero Therapeutics as of Q4 2024.

Based on AWM Investment Company's 13F filing for Q4 2024, filed 18 Feb 2025.